medline.ch Respirationstrakt Neoplasie

	Codelivery of nivolumab and Galunisertib by EGFR-targeted spherical polymeric nanoparticles for effective treatment of non-small cell lung cancer. Int J Pharm Kaplan M, Tavukçuo, Öztürk SC, Çal, Esenda, Öztürk K. PMID: 42648563 [PubMed - as supplied by publisher]
	Protocol of a randomized trial of "pathways," a hope intervention for people undergoing treatment for advanced lung cancer. Contemp Clin Trials McLouth LE, Blair C, Shelton BJ, Cheavens JS, Bursac V, Burris JL, Peterman AH, McFarlin J, Stapleton JL, Andreae L, Corum L, Cowley A, Arnold SM. PMID: 42648399 [PubMed - as supplied by publisher]
	De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment. Med Sci (Basel) Raphael A, Peled N, Gillis R, Nechushtan H, Shalata W, Dudnik E. PMID: 42646625 [PubMed - indexed for MEDLINE]
	Real-Time AI-Based Assessment of Glottic Lesions During Flexible Laryngoscopy: Comparison with Expert Evaluation and Histopathology. Med Sci (Basel) Kränzlein J, Anagnostopoulos K, Arens C, Davaris N. PMID: 42646592 [PubMed - indexed for MEDLINE]
	Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC. Med Sci (Basel) Abu-Rafe S, Shrem NS, Agbarya A, Miari A, Brenner R, Dudnik Y, Abu Jama A, Shalata S, Rouvinov K, Abu Yasin N, Tourkey L, Khalaily A, Bdair R, Yakobson A, Maimon Rabinovich N, Shalata W. PMID: 42646554 [PubMed - indexed for MEDLINE]
	Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS (THINKERS): an AI model for lung cancer brain metastases. J Neurooncol Reyes JS, Bouras A, Lunsford LD, Hadjipanayis CG, Niranjan A. PMID: 42645667 [PubMed - indexed for MEDLINE]
	Pain-Related Emergency Department Visits and Hospitalizations Following Hydrocodone Rescheduling in Metastatic Lung Cancer. Curr Oncol Shen C, Ikram M, Zhou S, Klein R, Leslie D, Thornton JD. PMID: 42645400 [PubMed - indexed for MEDLINE]
	Distinguishing Organizing Pneumonia from Malignancy During Cancer Surveillance: Predominant Diagnostic Value of Imaging over Systemic Inflammatory Biomarkers. Curr Oncol Yesilcay HB, Aydin AA. PMID: 42645396 [PubMed - indexed for MEDLINE]
	Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window. Curr Oncol Çil , M, Kutlu Y, Güren AK, Sar, Ökten , Atalah F, Bayda, K, Tural D, Bayramgil A, Balkaya Aykut G, Yumu, Erçin E, Do, Y, Han Ö, Güney B, Olcar S, Odaba, Bilici A, Özçelik M. PMID: 42645377 [PubMed - indexed for MEDLINE]
	Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives. Curr Oncol Daaboul N, Agulnik JS, Bahig H, Blais N, Boucher MÈ, Bouchard N, Denault MH, Desmeules P, Fiset PO, Florescu M, Jao K, Labbé C, Lecavalier-Barsoum M, Pepe C, Shieh B, Stock-Martineau S, Marcoux N. PMID: 42645370 [PubMed - indexed for MEDLINE]
	The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC. Curr Oncol Phillips WJ, Leong R, Yeung B, Al Lawati A, Camidge DR, Lo B, Wheatley-Price P. PMID: 42645345 [PubMed - indexed for MEDLINE]
	Nanocarrier-Based Drug Delivery Systems for Lung Cancer: A Systematic Review and Meta-Analysis of Preclinical Studies. Adv Respir Med Breznica Selmani P, Grapci AD, Koshi B, Sllamniku Dalipi Z, Koliqi R. PMID: 42644871 [PubMed - indexed for MEDLINE]
	Effects of non-intubated anesthesia on postoperative pulmonary complications after thoracoscopic segmentectomy: a propensity score-matched analysis. Ann Med Tan Y, Liu G, Wang D, Zhang Y, Li C, Zhao Y, Shan L, Li N. PMID: 42644232 [PubMed - indexed for MEDLINE]
	BDE47 exposure in lung adenocarcinoma: prognostic biomarkers, immune dysregulation, and mechanistic insights from toxicogenomic and docking studies. 3 Biotech Zhao M, Wu X, Mao Y, Wu M, Du J, Zhang Y, Wang Y. PMID: 42643788 [PubMed]
	Identification of PD-1-Related Genes as Prognostic Biomarkers in Lung Adenocarcinoma. Hum Mutat Jia B, Gong T, Chen C, Sun B, Zhang Z. PMID: 42643623 [PubMed - indexed for MEDLINE]
	Safety and efficacy of first-line iparomlimab and tuvonralimab (QL1706) plus carboplatin and etoposide in patients with extensive-stage small cell lung cancer: an open-label, single-arm, phase 2 trial (DUBHE-L-209). Front Immunol Fan Y, Yang R, Min X, Ma H, Wang Y, Zhao Y, Wang H, Zhang M, Wang H, Zhang T, Wang Z. PMID: 42643500 [PubMed - indexed for MEDLINE]
	A comprehensive prognostic model for older patients with advanced non-small cell lung cancer receiving immunotherapy: a multicenter real-world study. Front Immunol Song X, Lv J, Qi Y, Zheng H, Ren Z, Wang P, Sun H, Shen H. PMID: 42643427 [PubMed - indexed for MEDLINE]
	Granulocyte colony-stimulating factor use does not impair efficacy of chemoimmunotherapy in advanced non-small cell lung cancer: a real-world retrospective study. Front Immunol Yang R, Xia H, Zhang Y, Ma X, Sun X, Wang Z, Liu N, Zhang M, Wang X, Liu Y. PMID: 42643417 [PubMed - indexed for MEDLINE]
	Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC. Front Immunol Wang Y, Dong X, Yin Y, Lin Z, Ren P, Zheng Y, Wang H. PMID: 42643285 [PubMed - indexed for MEDLINE]
	Concurrent Stereotactic Radiotherapy and Immune Checkpoint Inhibitors for Multiple Brain Metastases in Non-Small Cell Lung Cancer - A Multi-Center Retrospective Analysis. CNS Neurosci Ther Wang X, Zheng Y, Wang A, Zhao X, Guan K, Huang Q, Du J. PMID: 42643012 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 162546

Seite 1 von 8128



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung